The next steps for genomic medicine: challenges and opportunities for the developing world
- 1 October 2008
- journal article
- Published by Springer Science and Business Media LLC in Nature Reviews Genetics
- Vol. 9 (S1), S23-S27
- https://doi.org/10.1038/nrg2444
Abstract
This is a historical moment on the path to genomic medicine - the point at which theory is about to be translated into practice. We have previously described human genome variation studies taking place in Mexico, India, Thailand, and South Africa. Such investments into science and technology will enable these countries to embark on the path to the medical and health applications of genomics, and to benefit economically. Here we provide a perspective on the challenges and opportunities facing these and other countries in the developing world as they begin to harness genomics for the benefit of their populations.Keywords
This publication has 25 references indexed in Scilit:
- Genomic Medicine: ‘Grand challenges’ in the translation of genomics to human healthEuropean Journal of Human Genetics, 2008
- Genomic medicine and developing countries: creating a room of their ownNature Reviews Genetics, 2008
- Research Ethics Recommendations for Whole-Genome Research: Consensus StatementPLoS Biology, 2008
- Implementing the U.S. FDA guidance on pharmacogenomic data submissionsEnvironmental and Molecular Mutagenesis, 2007
- UK Biobank: bank on itThe Lancet, 2007
- India's health biotech sector at a crossroadsNature Biotechnology, 2007
- A haplotype map of the human genomeNature, 2005
- A national DNA bank in The Gambia, West Africa, and genomic research in developing countriesNature Genetics, 2004
- The International HapMap ProjectNature, 2003
- Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twinsThe Lancet, 2002